Aura Biosciences Income Statement (2020-2026) | AURA

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
6.63M6.37M7.98M8.28M9.51M11.29M13.16M14.40M15.12M15.43M20.28M17.05M16.88M17.04M22.33M23.34M22.88M22.18M21.90M27.96M
Selling, General & Administrative (Quarter)
2.17M2.53M3.65M4.54M4.31M4.76M4.45M5.04M5.16M5.06M4.50M5.26M5.88M6.20M5.47M5.69M5.73M5.73M5.34M6.91M
Other Operating Expenses (Quarter)
-35.15M-0.01M
Operating Expenses (Quarter)
8.80M8.89M-23.52M12.81M13.82M16.05M17.61M19.44M20.28M20.49M24.78M22.31M22.76M23.23M27.81M29.04M28.61M27.91M27.24M34.87M
Operating Income (Quarter)
-8.80M-8.89M-11.63M-12.81M-13.82M-16.05M-17.61M-19.44M-20.28M-20.49M-24.78M-22.31M-22.76M-23.23M50.08M-29.04M-28.61M-27.91M63.28M-34.87M
EBIT (Quarter)
-8.80M-8.89M-11.63M-12.81M-13.82M-16.05M-17.61M-19.44M-20.28M-20.49M-24.78M-22.31M-22.76M-23.23M50.08M-29.04M-28.61M-27.91M63.28M-34.87M
Non-operating items
Non Operating Investment Income (Quarter)
-0.01M
Other Non Operating Income (Quarter)
0.05M-0.04M0.06M-0.33M0.31M-0.01M-0.03M-0.01M-0.03M-0.03M-0.03M-0.03M1.27M-0.02M-0.04M-0.01M1.86M0.00M
Non Operating Income (Quarter)
0.06M-0.00M-0.02M0.35M0.15M1.05M-0.01M-0.03M-0.01M2.79M2.65M-0.03M2.23M-0.04M1.57M1.64M1.80M1.69M0.00M
Net income details
EBT (Quarter)
-8.80M-8.89M-11.63M-12.81M-13.82M-16.05M-17.61M-17.47M-18.30M-18.51M-21.99M-19.66M-20.34M-21.00M-25.19M-27.46M-26.97M-26.10M-25.54M-33.67M
Tax Provisions (Quarter)
0.14M0.05M0.04M0.02M0.02M0.05M0.03M0.01M0.01M
Profit After Tax (Quarter)
-8.85M-8.84M-11.70M-12.84M-13.47M-15.90M-16.56M-17.47M-18.30M-18.51M-22.13M-19.71M-20.34M-21.04M-25.83M-27.48M-27.02M-26.13M-25.57M-33.69M
Income from Continuing Operations (Quarter)
-8.80M-8.89M-11.63M-12.81M-13.82M-16.05M-17.61M-17.47M-18.30M-18.51M-22.13M-19.71M-20.34M-21.04M-25.21M-27.48M-27.02M-26.13M-25.55M-33.69M
Consolidated Net Income (Quarter)
-8.80M-8.89M-11.63M-12.81M-13.82M-16.05M-17.61M-17.47M-18.30M-18.51M-22.13M-19.71M-20.34M-21.04M-25.21M-27.48M-27.02M-26.13M-25.55M-33.69M
Income towards Parent Company (Quarter)
-8.80M-8.89M-11.63M-12.81M-13.82M-16.05M-17.61M-17.47M-18.30M-18.51M-22.13M-19.71M-20.34M-21.04M-25.21M-27.48M-27.02M-26.13M-25.55M-33.69M
Net Income towards Common Stockholders (Quarter)
-8.80M-8.89M-11.63M-12.81M-13.82M-16.05M-17.61M-17.47M-18.30M-18.51M-22.13M-19.71M-20.34M-21.04M-25.21M-27.48M-27.02M-26.13M-25.55M-33.69M
Additional items
EPS (Basic) (Quarter)
-28.53-28.3368.98-0.44-0.46-0.54-0.52-0.46-0.48-0.48-0.50-0.40-0.41-0.42-0.52-0.55-0.47-0.40-0.37-0.50
EPS (Weighted Average and Diluted) (Quarter)
-28.53-28.3368.98-0.44-0.46-0.54-0.52-0.46-0.48-0.48-0.50-0.40-0.41-0.42-0.52-0.55-0.47-0.40-0.37-0.50
Shares Outstanding (Weighted Average) (Quarter)
0.17M0.43M5.16M29.21M29.25M29.27M29.94M37.78M37.86M38.19M39.62M0.01M0.01M49.55M49.65M50.13M58.02M65.94M7.40M67.45M
Shares Outstanding (Diluted Average) (Quarter)
0.44M0.44M5.16M29.21M29.23M29.27M29.94M37.78M37.86M38.19M39.62M49.45M49.50M49.55M49.65M50.13M54.09M65.94M60.34M67.45M
EBITDA (Quarter)
-8.85M-8.84M-11.63M-12.84M-13.59M-15.92M-16.48M-17.44M-18.48M-18.42M-21.46M-20.23M-20.54M-20.25M-26.18M-27.64M-27.10M-26.09M-25.73M-33.79M
Tax Rate (Quarter)
-0.62%-0.25%-0.20%-0.10%-0.07%-0.18%-0.10%-0.03%-0.03%